Drug Eluting Stents Market, By Product Type (Polymer-based Coatings, Polymer free Coatings (Micro porous Surface, Micro structured Surface, Slotted Tubular Surface, and Nanoporous Surface), By Application (Coronary Artery Disease, Peripheral Artery Disease, and Others), By End User (Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Jan 2025

Code : CMI566

Pages :150

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Drug Eluting Stents Market Regional Insights

To learn more about this report, Request sample copy

North America Drug Eluting Stents Market Trends

North America’s dominance in the drug eluting stents market with share of 35.3% in 2024 can be attributed to factors such as the well-established healthcare infrastructure, growing prevalence of cardiovascular diseases, and presence of leading market players. Favorable reimbursement policies have also contributed to the large market size in the region.

Asia Pacific Drug Eluting Stents Market Trends

The Asia Pacific region exhibits the fastest growth with share of 27.7% in 2024 and is expected to witness significant expansion over the forecast period. This can be credited to the improving access to healthcare in developing nations, rising medical tourism, and increasing healthcare expenditures.

Drug Eluting Stents Market Outlook for Key Countries

United States Drug Eluting Stents Market Trends

The U.S. dominated the drug eluting stents market with, driven by strong healthcare infrastructure, high adoption of advanced technologies. For Instance, In June 2021, such Abbott, global healthcare leader announced USFDA approval for one-month dual antiplatelet therapy (DAPT) labeling for its XIENCE stents in high bleeding risk (HBR) patients. XIENCE stents also received CE Mark approval, making them the world’s shortest DAPT-indicated stents.

Japan Drug Eluting Stents Market Trends

Japan’s aging population significantly drives the demand for drug eluting stents. In February 2023, the Japanese Ministry of Health reported an increase in funding for cardiovascular treatments, including drug eluting stents, to address the growing health needs of the elderly.

Germany Drug Eluting Stents Market Trends

Germany drug eluting stents market benefits from strong government support for cardiovascular health initiatives. In March 2023, the German Federal Ministry of Health announced funding for innovative medical technologies, including drug eluting stents, to improve patient care and outcomes.

India Drug Eluting Stents Market Trends

India's market for drug eluting stents is expanding due to rising healthcare investments and increasing awareness about cardiovascular diseases. In April 2023, the Indian Council of Medical Research launched a national initiative to promote the use of drug eluting stents for better management of heart diseases.